Chris Mason on Muck Rack

Chris Mason

Verified
San Diego
As seen in: Cell & Gene Therapy Insights, Regenerative Medicine, Future Medicine
Professor of Cell & Gene Therapy, University College London | Senior Editor: 'Cell & Gene Therapy Insights' + 'Regenerative Medicine'
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Chris

Contact Chris, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The evolving realm of nucleic acids: past, present, and future

|
By Chris Mason Verified
With over 30 years in translational R&D, Chris Mason has focused his career on addressing the critical question of how to enable people worldwide to have access to cell and gene therapies. On November 16, 2023, David McCall, Senior Editor, Nucleic Acid Insights, spoke to Chris about trends in the nucleic acids field. This Viewpoint article is based on that conversation.
Open in Who Shared Issue with article?

Latest developments in the field of stem cell research and regenerative medicine compiled from publicly available information and press releases from nonacademic institutions in December 2018

|
By Ilic Dusko, Dusko Ilic, Chris Mason Verified, Peter Dunnill
| Future Medicine Verified
Business development Collaborations, partnerships & alliances Co-development agreement: Gilead & Agenus Gilead (CA, USA; www.gilead.com) and Agenus (MA, USA; www.agenusbio.com) announced today the companies have entered into an immuno-oncology partnership focused on the development and commercialization of up to five novel immuno-oncology therapies.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified